Letter to the Editor: Drug-Induced Liver Injury with Ritonavir-Boosted Nirmatrelvir: Evidence from COVID-19 EUA Adverse Event Reporting System

HOME
>
論文・技術情報
>
Letter to the Editor: Drug-Induced Liver Injury with Ritonavir-Boosted Nirmatrelvir: Evidence from COVID-19 EUA Adverse Event Reporting System – Authors’ reply.

Letter to the Editor: Drug-Induced Liver Injury with Ritonavir-Boosted Nirmatrelvir: Evidence from COVID-19 EUA Adverse Event Reporting System – Authors’ reply.

アブストラクト
ジャーナル名	Gastroenterology
Pubmed追加日	2023/4/13
投稿者	Lai-Hung Wong, Grace; Wing-Ki Hui, Vicki; Cheuk-Fung Yip, Terry
組織名	Department of Medicine and Therapeutics; Medical Data Analytics Centre (MDAC);;Institute of Digestive Disease, The Chinese University of Hong Kong; Hong Kong.;Electronic address: tcfyip@cuhk.edu.hk.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/37044273/